Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0379520010170030235
Çѱ¹µ¶¼ºÇÐȸÁö
2001 Volume.17 No. 3 p.235 ~ p.239
Mutagenicity Tests on CJ-50005 (Hepatitis A Vaccine)
Kim Jong-Ho

Lee Eun-Young
Kim Dal-Hyun
Kim Hyun-Seok
Abstract
CJ-50005 is an inactivated whole virus vaccine derived from hepatitis A virus (HM175) grown in human MRC-5 diploid fibroblasts cell culture. In order to evaluate the mutagenic potential of CJ-50005, : 3 sets of mutagenicity tests were performed. In the reverse mutation test wing Salmonella typhimurium TA1535, TA1 537, TA98, TA100 and TA102, CJ-50005 did not increase the number of revertants at any concentration tested in this study (2.8, 1.4, 0.7, 0.35 and 0.175 mutextrm{g}/plate). CJ-50005, at concentration of 2.8, 1.4 and 0.7 mutextrm{g}/ml, did not increase the number of cells having structural or numerical chromosome aberration in cytogenic test using Chinese Hamster Lung cells. In mouse micronucleus test, no significant increase in the occurrence of micronucleated polychromatic erythrocytes was observed in ICR male and female mice intraperitoneally administered with CJ-50005 at the doses of 25, 12.5 and 6.25 mutextrm{g}/kg. These results indicate that CJ-50005 has no mutagenic potential in these in vitro and in vivo system.
KEYWORD
Reverse mutation, Chromosome aberration, Micronucleus, Hepatitis A virus, CJ-50005
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed